Stapled Phd Peptides Inhibit Doc Toxin Induced Growth Arrest in Salmonella

Area of Science:

• Microbiology
• Molecular Biology
• Drug Discovery

Background:

• Antibiotic resistance is a growing global health threat, necessitating novel therapeutic strategies.
• Bacterial persister cells contribute to antibiotic treatment failure by exhibiting tolerance to antimicrobial agents.
• The Doc toxin in Salmonella plays a role in the formation of antibiotic-tolerant persister cells.

Purpose of the Study:

• To develop novel therapeutic agents targeting bacterial toxins.
• To create first-in-class stapled peptide antitoxin mimetics based on the Phd antitoxin sequence.
• To evaluate the efficacy of these peptide mimetics in counteracting Doc toxicity and reducing antibiotic persistence in Salmonella.

Main Methods:

• Design and synthesis of stapled peptide mimetics based on the Phd antitoxin.
• Introduction of substitutions to enhance bacterial uptake of the peptides.
• In vitro and in vivo assays to assess the inhibition of Doc toxicity in Salmonella.
• Evaluation of the impact of the lead peptide on antibiotic persistence.

Main Results:

• Successful development of first-in-class stapled peptide antitoxin mimetics.
• Identification of a lead stapled Phd peptide with improved bacterial uptake.
• Demonstration that the lead peptide effectively counteracts Doc toxicity in Salmonella.
• Evidence suggesting the potential of this approach to reduce antibiotic persistence.

Conclusions:

• Stapled peptide antitoxin mimetics represent a promising new class of therapeutics.
• The developed Phd-based stapled peptide is a viable starting point for combating antibiotic persistence.
• This research opens avenues for developing novel peptide-based strategies against pathogenic bacteria and antibiotic failure.